EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹394 Cr | ₹286 Cr | ₹97 Cr | ₹12 Cr | ₹13 Cr |
What is the latest Contingent Liabilities ratio of EMCURE PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹394 Cr |
| Mar2024 | ₹286 Cr |
| Mar2023 | ₹97 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹13 Cr |
How is Contingent Liabilities of EMCURE PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹394 Cr | 37.98 | |
| Mar2024 | ₹286 Cr | 194.49 | |
| Mar2023 | ₹97 Cr | 703.28 | |
| Mar2022 | ₹12 Cr | -5.66 | |
| Mar2021 | ₹13 Cr | - | |
Compare Contingent Liabilities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹29,200.3 Cr | 3.2% | 9.2% | 7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 3.2% |
9.2% |
7.3% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses